---
title: "Weekly Recap | LexinFintech -25.28%, Q3 loss warning"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/298099552.md"
description: "LexinFintech (LX) fell 25.28% this week to close at $0.8817. The S&P 500 edged up 0.09%, so LX underperformed the benchmark by roughly 25.37 percentage points. The week opened with a pop to $1.090 on Monday 31 Aug, but the move faded fast. Tuesday brought a heavy drop toward $0.8653, Wednesday closed at $0.8209, and Thursday printed an intraday low of $0.7831 before a modest bounce to $0.8817 on Friday. Weekly amplitude was 30.39%."
datetime: "2026-09-05T07:19:11.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/298099552.md)
  - [en](https://longbridge.com/en/news/298099552.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/298099552.md)
generator: "portal-rs"
---

# Weekly Recap | LexinFintech -25.28%, Q3 loss warning

## The Week

LexinFintech (LX) fell 25.28% this week to close at $0.8817. The S&P 500 edged up 0.09%, so LX underperformed the benchmark by roughly 25.37 percentage points. The week opened with a pop to $1.090 on Monday 31 Aug, but the move faded fast. Tuesday brought a heavy drop toward $0.8653, Wednesday closed at $0.8209, and Thursday printed an intraday low of $0.7831 before a modest bounce to $0.8817 on Friday. Weekly amplitude was 30.39%.

## Key Events

On Monday, Lexin reported unaudited Q2 2026 results: revenue fell 11% year on year, net profit dropped 76%, and non-GAAP EPADS came in at $0.11. The company also gave Q3 guidance, warned of a possible loss, and moved its dividend to an annual payout. The earnings call the same day highlighted funding strain and a strategic pivot. Shares fell in response, especially from Monday to Wednesday, while US-listed Chinese ADRs broadly weakened overnight, adding pressure to the name.

## Analyst Ratings

Five institutions cover Lexin. Of these, 1 rates it buy, 1 rates it overweight, and 3 rate it hold, with no underweight or sell ratings. The consensus rating is buy, and the consensus target price is $2.1299, about 141.57% above the latest price. Target prices range from $0.950 to $4.834, which points to wide disagreement. Lexin ranks 25th among 43 names in the consumer finance industry.

## The Week Ahead

The US calendar includes the NFIB Small Business Optimism Index on 8 Sep, followed on 10 Sep by initial jobless claims, final demand PPI, core PPI, existing home sales, wholesale sales, and EIA natural gas storage. The 10-year Treasury auction also lands on 10 Sep. Any surprise in these prints could shift sentiment for US-listed Chinese ADRs, so the macro side is worth watching alongside company-specific news.

## In Short

Lexin had a bruising week: weak Q2 numbers, a Q3 loss warning, and a dividend policy change landed together, and the stock slid sharply against a nearly flat S&P 500. Analysts still rate it a consensus buy with a target price well above spot, but the wide target range and a middling industry rank show the divergence. Valuation sits at just 0.08x PB and 0.97x PE, while the latest session’s capital flow shows large-lot selling pressure. The key question ahead is how deep the Q3 loss turns out to be, and how macro data shapes risk appetite for Chinese ADRs.

*This article is generated by LongbridgeAI from market data, for information only and not investment advice.*

### Related Stocks

- [LX.US](https://longbridge.com/en/quote/LX.US.md)

## Related News & Research

- [LexinFintech stock tumbles after warning of Q3 loss, changing dividend to annual distribution](https://longbridge.com/en/news/297521064.md)
- [LX Holdings raises MTBE plant investment to KRW 74 billion in correction filing](https://longbridge.com/en/news/301679818.md)
- [TTM Technologies Q3 net income jumps 60% to $84.8 million; Q3 net sales rise 60% to $1.2 billion](https://longbridge.com/en/news/302693400.md)
- [Tesla CFO Says Revising Capex Guidance To $20 Billion This Year](https://longbridge.com/en/news/302617804.md)
- [Micron introduces quarterly employee bonus tied to profits](https://longbridge.com/en/news/302675659.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**